Active ingredients: atovaquone
What it is used for
Wellvone suspension is indicated for: Acute treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) (difference of alveolar and arterial oxygen tensions [(A-a)DO2]<=45mmHg(6kPa) and oxygen tension in arterial blood (Pa02)>=60mmHg(8kPa) breathing room air) in adult patients with AIDS who are intolerant of trimethoprim/sulphamethoxazole therapy.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Do not Freeze
- Do not Dilute
- Lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Bright yellow suspension with a sweet, fruity odour.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
Is this medicine subsidised?
This medicine is subsidised which may make it cheaper. To learn more about this subsidy, visit the Phamaceutical Benefits Scheme (PBS) website
Pregnant or planning a pregnancy?
For the active ingredient atovaquone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)